These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 20852631)

  • 21. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Antoniou AC; Spurdle AB; Sinilnikova OM; Healey S; Pooley KA; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Hofmann W; Sutter C; Niederacher D; Deissler H; Caldes T; Kämpjärvi K; Nevanlinna H; Simard J; Beesley J; Chen X; ; Neuhausen SL; Rebbeck TR; Wagner T; Lynch HT; Isaacs C; Weitzel J; Ganz PA; Daly MB; Tomlinson G; Olopade OI; Blum JL; Couch FJ; Peterlongo P; Manoukian S; Barile M; Radice P; Szabo CI; Pereira LH; Greene MH; Rennert G; Lejbkowicz F; Barnett-Griness O; Andrulis IL; Ozcelik H; ; Gerdes AM; Caligo MA; Laitman Y; Kaufman B; Milgrom R; Friedman E; ; Domchek SM; Nathanson KL; Osorio A; Llort G; Milne RL; Benítez J; Hamann U; Hogervorst FB; Manders P; Ligtenberg MJ; van den Ouweland AM; ; Peock S; Cook M; Platte R; Evans DG; Eeles R; Pichert G; Chu C; Eccles D; Davidson R; Douglas F; ; Godwin AK; Barjhoux L; Mazoyer S; Sobol H; Bourdon V; Eisinger F; Chompret A; Capoulade C; Bressac-de Paillerets B; Lenoir GM; Gauthier-Villars M; Houdayer C; Stoppa-Lyonnet D; ; Chenevix-Trench G; Easton DF;
    Am J Hum Genet; 2008 Apr; 82(4):937-48. PubMed ID: 18355772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The spectrum of BRCA1 and BRCA2 mutations and clinicopathological characteristics in Chinese women with early-onset breast cancer.
    Chen L; Fu F; Huang M; Lv J; Zhang W; Wang C
    Breast Cancer Res Treat; 2020 Apr; 180(3):759-766. PubMed ID: 32072338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
    Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
    Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.
    Kuchenbaecker KB; Neuhausen SL; Robson M; Barrowdale D; McGuffog L; Mulligan AM; Andrulis IL; Spurdle AB; Schmidt MK; Schmutzler RK; Engel C; Wappenschmidt B; Nevanlinna H; Thomassen M; Southey M; Radice P; Ramus SJ; Domchek SM; Nathanson KL; Lee A; Healey S; Nussbaum RL; Rebbeck TR; Arun BK; James P; Karlan BY; Lester J; Cass I; ; Terry MB; Daly MB; Goldgar DE; Buys SS; Janavicius R; Tihomirova L; Tung N; Dorfling CM; van Rensburg EJ; Steele L; v O Hansen T; Ejlertsen B; Gerdes AM; Nielsen FC; Dennis J; Cunningham J; Hart S; Slager S; Osorio A; Benitez J; Duran M; Weitzel JN; Tafur I; Hander M; Peterlongo P; Manoukian S; Peissel B; Roversi G; Scuvera G; Bonanni B; Mariani P; Volorio S; Dolcetti R; Varesco L; Papi L; Tibiletti MG; Giannini G; Fostira F; Konstantopoulou I; Garber J; Hamann U; Donaldson A; Brewer C; Foo C; Evans DG; Frost D; Eccles D; ; Douglas F; Brady A; Cook J; Tischkowitz M; Adlard J; Barwell J; Ong KR; Walker L; Izatt L; Side LE; Kennedy MJ; Rogers MT; Porteous ME; Morrison PJ; Platte R; Eeles R; Davidson R; Hodgson S; Ellis S; Godwin AK; Rhiem K; Meindl A; Ditsch N; Arnold N; Plendl H; Niederacher D; Sutter C; Steinemann D; Bogdanova-Markov N; Kast K; Varon-Mateeva R; Wang-Gohrke S; Gehrig A; Markiefka B; Buecher B; Lefol C; Stoppa-Lyonnet D; Rouleau E; Prieur F; Damiola F; ; Barjhoux L; Faivre L; Longy M; Sevenet N; Sinilnikova OM; Mazoyer S; Bonadona V; Caux-Moncoutier V; Isaacs C; Van Maerken T; Claes K; Piedmonte M; Andrews L; Hays J; Rodriguez GC; Caldes T; de la Hoya M; Khan S; Hogervorst FB; Aalfs CM; de Lange JL; Meijers-Heijboer HE; van der Hout AH; Wijnen JT; van Roozendaal KE; Mensenkamp AR; van den Ouweland AM; van Deurzen CH; van der Luijt RB; ; Olah E; Diez O; Lazaro C; Blanco I; Teulé A; Menendez M; Jakubowska A; Lubinski J; Cybulski C; Gronwald J; Jaworska-Bieniek K; Durda K; Arason A; Maugard C; Soucy P; Montagna M; Agata S; Teixeira MR; ; Olswold C; Lindor N; Pankratz VS; Hallberg E; Wang X; Szabo CI; Vijai J; Jacobs L; Corines M; Lincoln A; Berger A; Fink-Retter A; Singer CF; Rappaport C; Kaulich DG; Pfeiler G; Tea MK; Phelan CM; Mai PL; Greene MH; Rennert G; Imyanitov EN; Glendon G; Toland AE; Bojesen A; Pedersen IS; Jensen UB; Caligo MA; Friedman E; Berger R; Laitman Y; Rantala J; Arver B; Loman N; Borg A; Ehrencrona H; Olopade OI; Simard J; Easton DF; Chenevix-Trench G; Offit K; Couch FJ; Antoniou AC;
    Breast Cancer Res; 2014 Dec; 16(6):3416. PubMed ID: 25919761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.
    Couch FJ; Kuchenbaecker KB; Michailidou K; Mendoza-Fandino GA; Nord S; Lilyquist J; Olswold C; Hallberg E; Agata S; Ahsan H; Aittomäki K; Ambrosone C; Andrulis IL; Anton-Culver H; Arndt V; Arun BK; Arver B; Barile M; Barkardottir RB; Barrowdale D; Beckmann L; Beckmann MW; Benitez J; Blank SV; Blomqvist C; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Brauch H; Brenner H; Burwinkel B; Buys SS; Caldes T; Caligo MA; Canzian F; Carpenter J; Chang-Claude J; Chanock SJ; Chung WK; Claes KB; Cox A; Cross SS; Cunningham JM; Czene K; Daly MB; Damiola F; Darabi H; de la Hoya M; Devilee P; Diez O; Ding YC; Dolcetti R; Domchek SM; Dorfling CM; Dos-Santos-Silva I; Dumont M; Dunning AM; Eccles DM; Ehrencrona H; Ekici AB; Eliassen H; Ellis S; Fasching PA; Figueroa J; Flesch-Janys D; Försti A; Fostira F; Foulkes WD; Friebel T; Friedman E; Frost D; Gabrielson M; Gammon MD; Ganz PA; Gapstur SM; Garber J; Gaudet MM; Gayther SA; Gerdes AM; Ghoussaini M; Giles GG; Glendon G; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Greene MH; Gronwald J; Guénel P; Gunter M; Haeberle L; Haiman CA; Hamann U; Hansen TV; Hart S; Healey S; Heikkinen T; Henderson BE; Herzog J; Hogervorst FB; Hollestelle A; Hooning MJ; Hoover RN; Hopper JL; Humphreys K; Hunter DJ; Huzarski T; Imyanitov EN; Isaacs C; Jakubowska A; James P; Janavicius R; Jensen UB; John EM; Jones M; Kabisch M; Kar S; Karlan BY; Khan S; Khaw KT; Kibriya MG; Knight JA; Ko YD; Konstantopoulou I; Kosma VM; Kristensen V; Kwong A; Laitman Y; Lambrechts D; Lazaro C; Lee E; Le Marchand L; Lester J; Lindblom A; Lindor N; Lindstrom S; Liu J; Long J; Lubinski J; Mai PL; Makalic E; Malone KE; Mannermaa A; Manoukian S; Margolin S; Marme F; Martens JW; McGuffog L; Meindl A; Miller A; Milne RL; Miron P; Montagna M; Mazoyer S; Mulligan AM; Muranen TA; Nathanson KL; Neuhausen SL; Nevanlinna H; Nordestgaard BG; Nussbaum RL; Offit K; Olah E; Olopade OI; Olson JE; Osorio A; Park SK; Peeters PH; Peissel B; Peterlongo P; Peto J; Phelan CM; Pilarski R; Poppe B; Pylkäs K; Radice P; Rahman N; Rantala J; Rappaport C; Rennert G; Richardson A; Robson M; Romieu I; Rudolph A; Rutgers EJ; Sanchez MJ; Santella RM; Sawyer EJ; Schmidt DF; Schmidt MK; Schmutzler RK; Schumacher F; Scott R; Senter L; Sharma P; Simard J; Singer CF; Sinilnikova OM; Soucy P; Southey M; Steinemann D; Stenmark-Askmalm M; Stoppa-Lyonnet D; Swerdlow A; Szabo CI; Tamimi R; Tapper W; Teixeira MR; Teo SH; Terry MB; Thomassen M; Thompson D; Tihomirova L; Toland AE; Tollenaar RA; Tomlinson I; Truong T; Tsimiklis H; Teulé A; Tumino R; Tung N; Turnbull C; Ursin G; van Deurzen CH; van Rensburg EJ; Varon-Mateeva R; Wang Z; Wang-Gohrke S; Weiderpass E; Weitzel JN; Whittemore A; Wildiers H; Winqvist R; Yang XR; Yannoukakos D; Yao S; Zamora MP; Zheng W; Hall P; Kraft P; Vachon C; Slager S; Chenevix-Trench G; Pharoah PD; Monteiro AA; García-Closas M; Easton DF; Antoniou AC
    Nat Commun; 2016 Apr; 7():11375. PubMed ID: 27117709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
    Heikkinen T; Kärkkäinen H; Aaltonen K; Milne RL; Heikkilä P; Aittomäki K; Blomqvist C; Nevanlinna H
    Clin Cancer Res; 2009 May; 15(9):3214-22. PubMed ID: 19383810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological characteristics of BRCA-associated breast cancers in Hispanics.
    Lagos-Jaramillo VI; Press MF; Ricker CN; Dubeau L; Mai PL; Weitzel JN
    Breast Cancer Res Treat; 2011 Nov; 130(1):281-9. PubMed ID: 21604016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.
    Tommasi S; Fedele V; Lacalamita R; Bruno M; Schittulli F; Ginzinger D; Scott G; Eppenberger-Castori S; Calistri D; Casadei S; Seymour I; Longo S; Giannelli G; Pilato B; Simone G; Benz CC; Paradiso A
    Cell Oncol; 2007; 29(3):241-8. PubMed ID: 17452776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.
    Comen E; Davids M; Kirchhoff T; Hudis C; Offit K; Robson M
    Breast Cancer Res Treat; 2011 Aug; 129(1):185-90. PubMed ID: 21394499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.
    Fostira F; Tsitlaidou M; Papadimitriou C; Pertesi M; Timotheadou E; Stavropoulou AV; Glentis S; Bournakis E; Bobos M; Pectasides D; Papakostas P; Pentheroudakis G; Gogas H; Skarlos P; Samantas E; Bafaloukos D; Kosmidis PA; Koutras A; Yannoukakos D; Konstantopoulou I; Fountzilas G
    Breast Cancer Res Treat; 2012 Jul; 134(1):353-62. PubMed ID: 22434525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
    Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
    Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of three SNPs in TOX3 and breast cancer risk: Evidence from 97275 cases and 128686 controls.
    Zhang L; Long X
    Sci Rep; 2015 Aug; 5():12773. PubMed ID: 26239137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
    Milne RL; Goode EL; García-Closas M; Couch FJ; Severi G; Hein R; Fredericksen Z; Malats N; Zamora MP; Arias Pérez JI; Benítez J; Dörk T; Schürmann P; Karstens JH; Hillemanns P; Cox A; Brock IW; Elliot G; Cross SS; Seal S; Turnbull C; Renwick A; Rahman N; Shen CY; Yu JC; Huang CS; Hou MF; Nordestgaard BG; Bojesen SE; Lanng C; Grenaker Alnæs G; Kristensen V; Børrensen-Dale AL; Hopper JL; Dite GS; Apicella C; Southey MC; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Chang-Claude J; Wang-Gohrke S; Radice P; Peterlongo P; Manoukian S; Barile M; Giles GG; Baglietto L; John EM; Miron A; Chanock SJ; Lissowska J; Sherman ME; Figueroa JD; Bogdanova NV; Antonenkova NN; Zalutsky IV; Rogov YI; Fasching PA; Bayer CM; Ekici AB; Beckmann MW; Brenner H; Müller H; Arndt V; Stegmaier C; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Meindl A; Heil J; Bartram CR; Schmutzler RK; Thomas GD; Hoover RN; Fletcher O; Gibson LJ; dos Santos Silva I; Peto J; Nickels S; Flesch-Janys D; Anton-Culver H; Ziogas A; Sawyer E; Tomlinson I; Kerin M; Miller N; Schmidt MK; Broeks A; Van 't Veer LJ; Tollenaar RA; Pharoah PD; Dunning AM; Pooley KA; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Jakubowska A; Lubinski J; Jaworska K; Durda K; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Kraft P; Lindstrom S; Chen X; Beesley J; Hamann U; Harth V; Justenhoven C; ; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning M; Hollestelle A; Oldenburg RA; Tilanus-Linthorst M; Khusnutdinova E; Bermisheva M; Prokofieva D; Farahtdinova A; Olson JE; Wang X; Humphreys MK; Wang Q; Chenevix-Trench G; ; ; Easton DF
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2222-31. PubMed ID: 21795498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
    Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
    Couch FJ; Sinilnikova O; Vierkant RA; Pankratz VS; Fredericksen ZS; Stoppa-Lyonnet D; Coupier I; Hughes D; Hardouin A; Berthet P; Peock S; Cook M; Baynes C; Hodgson S; Morrison PJ; Porteous ME; Jakubowska A; Lubinski J; Gronwald J; Spurdle AB; ; Schmutzler R; Versmold B; Engel C; Meindl A; Sutter C; Horst J; Schaefer D; Offit K; Kirchhoff T; Andrulis IL; Ilyushik E; Glendon G; Devilee P; Vreeswijk MP; Vasen HF; Borg A; Backenhorn K; Struewing JP; Greene MH; Neuhausen SL; Rebbeck TR; Nathanson K; Domchek S; Wagner T; Garber JE; Szabo C; Zikan M; Foretova L; Olson JE; Sellers TA; Lindor N; Nevanlinna H; Tommiska J; Aittomaki K; Hamann U; Rashid MU; Torres D; Simard J; Durocher F; Guenard F; Lynch HT; Isaacs C; Weitzel J; Olopade OI; Narod S; Daly MB; Godwin AK; Tomlinson G; Easton DF; Chenevix-Trench G; Antoniou AC;
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1416-21. PubMed ID: 17627006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.
    Osorio A; Milne RL; Kuchenbaecker K; Vaclová T; Pita G; Alonso R; Peterlongo P; Blanco I; de la Hoya M; Duran M; Díez O; Ramón Y Cajal T; Konstantopoulou I; Martínez-Bouzas C; Andrés Conejero R; Soucy P; McGuffog L; Barrowdale D; Lee A; ; Arver B; Rantala J; Loman N; Ehrencrona H; Olopade OI; Beattie MS; Domchek SM; Nathanson K; Rebbeck TR; Arun BK; Karlan BY; Walsh C; Lester J; John EM; Whittemore AS; Daly MB; Southey M; Hopper J; Terry MB; Buys SS; Janavicius R; Dorfling CM; van Rensburg EJ; Steele L; Neuhausen SL; Ding YC; Hansen TV; Jønson L; Ejlertsen B; Gerdes AM; Infante M; Herráez B; Moreno LT; Weitzel JN; Herzog J; Weeman K; Manoukian S; Peissel B; Zaffaroni D; Scuvera G; Bonanni B; Mariette F; Volorio S; Viel A; Varesco L; Papi L; Ottini L; Tibiletti MG; Radice P; Yannoukakos D; Garber J; Ellis S; Frost D; Platte R; Fineberg E; Evans G; Lalloo F; Izatt L; Eeles R; Adlard J; Davidson R; Cole T; Eccles D; Cook J; Hodgson S; Brewer C; Tischkowitz M; Douglas F; Porteous M; Side L; Walker L; Morrison P; Donaldson A; Kennedy J; Foo C; Godwin AK; Schmutzler RK; Wappenschmidt B; Rhiem K; Engel C; Meindl A; Ditsch N; Arnold N; Plendl HJ; Niederacher D; Sutter C; Wang-Gohrke S; Steinemann D; Preisler-Adams S; Kast K; Varon-Mateeva R; Gehrig A; Stoppa-Lyonnet D; Sinilnikova OM; Mazoyer S; Damiola F; Poppe B; Claes K; Piedmonte M; Tucker K; Backes F; Rodríguez G; Brewster W; Wakeley K; Rutherford T; Caldés T; Nevanlinna H; Aittomäki K; Rookus MA; van Os TA; van der Kolk L; de Lange JL; Meijers-Heijboer HE; van der Hout AH; van Asperen CJ; Gómez Garcia EB; Hoogerbrugge N; Collée JM; van Deurzen CH; van der Luijt RB; Devilee P; ; Olah E; Lázaro C; Teulé A; Menéndez M; Jakubowska A; Cybulski C; Gronwald J; Lubinski J; Durda K; Jaworska-Bieniek K; Johannsson OT; Maugard C; Montagna M; Tognazzo S; Teixeira MR; Healey S; ; Olswold C; Guidugli L; Lindor N; Slager S; Szabo CI; Vijai J; Robson M; Kauff N; Zhang L; Rau-Murthy R; Fink-Retter A; Singer CF; Rappaport C; Geschwantler Kaulich D; Pfeiler G; Tea MK; Berger A; Phelan CM; Greene MH; Mai PL; Lejbkowicz F; Andrulis I; Mulligan AM; Glendon G; Toland AE; Bojesen A; Pedersen IS; Sunde L; Thomassen M; Kruse TA; Jensen UB; Friedman E; Laitman Y; Shimon SP; Simard J; Easton DF; Offit K; Couch FJ; Chenevix-Trench G; Antoniou AC; Benitez J
    PLoS Genet; 2014 Apr; 10(4):e1004256. PubMed ID: 24698998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D Receptor Gene Polymorphism: Association with Susceptibility to Early-Onset Breast Cancer in Iranian, BRCA1/2-Mutation Carrier and non-carrier Patients.
    Shahabi A; Alipour M; Safiri H; Tavakol P; Alizadeh M; Milad Hashemi S; Shahabi M; Halimi M
    Pathol Oncol Res; 2018 Jul; 24(3):601-607. PubMed ID: 28780723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
    Lawrenson K; Kar S; McCue K; Kuchenbaeker K; Michailidou K; Tyrer J; Beesley J; Ramus SJ; Li Q; Delgado MK; Lee JM; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Arun BK; Arver B; Bandera EV; Barile M; Barkardottir RB; Barrowdale D; Beckmann MW; Benitez J; Berchuck A; Bisogna M; Bjorge L; Blomqvist C; Blot W; Bogdanova N; Bojesen A; Bojesen SE; Bolla MK; Bonanni B; Børresen-Dale AL; Brauch H; Brennan P; Brenner H; Bruinsma F; Brunet J; Buhari SA; Burwinkel B; Butzow R; Buys SS; Cai Q; Caldes T; Campbell I; Canniotto R; Chang-Claude J; Chiquette J; Choi JY; Claes KB; ; Cook LS; Cox A; Cramer DW; Cross SS; Cybulski C; Czene K; Daly MB; Damiola F; Dansonka-Mieszkowska A; Darabi H; Dennis J; Devilee P; Diez O; Doherty JA; Domchek SM; Dorfling CM; Dörk T; Dumont M; Ehrencrona H; Ejlertsen B; Ellis S; ; Engel C; Lee E; Evans DG; Fasching PA; Feliubadalo L; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Foretova L; Fostira F; Foulkes WD; Fridley BL; Friedman E; Frost D; Gambino G; Ganz PA; Garber J; García-Closas M; Gentry-Maharaj A; Ghoussaini M; Giles GG; Glasspool R; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Goode EL; Goodman MT; Greene MH; Gronwald J; Guénel P; Haiman CA; Hall P; Hallberg E; Hamann U; Hansen TV; Harrington PA; Hartman M; Hassan N; Healey S; ; Heitz F; Herzog J; Høgdall E; Høgdall CK; Hogervorst FB; Hollestelle A; Hopper JL; Hulick PJ; Huzarski T; Imyanitov EN; ; ; Isaacs C; Ito H; Jakubowska A; Janavicius R; Jensen A; John EM; Johnson N; Kabisch M; Kang D; Kapuscinski M; Karlan BY; Khan S; Kiemeney LA; Kjaer SK; Knight JA; Konstantopoulou I; Kosma VM; Kristensen V; Kupryjanczyk J; Kwong A; de la Hoya M; Laitman Y; Lambrechts D; Le N; De Leeneer K; Lester J; Levine DA; Li J; Lindblom A; Long J; Lophatananon A; Loud JT; Lu K; Lubinski J; Mannermaa A; Manoukian S; Le Marchand L; Margolin S; Marme F; Massuger LF; Matsuo K; Mazoyer S; McGuffog L; McLean C; McNeish I; Meindl A; Menon U; Mensenkamp AR; Milne RL; Montagna M; Moysich KB; Muir K; Mulligan AM; Nathanson KL; Ness RB; Neuhausen SL; Nevanlinna H; Nord S; Nussbaum RL; Odunsi K; Offit K; Olah E; Olopade OI; Olson JE; Olswold C; O'Malley D; Orlow I; Orr N; Osorio A; Park SK; Pearce CL; Pejovic T; Peterlongo P; Pfeiler G; Phelan CM; Poole EM; Pylkäs K; Radice P; Rantala J; Rashid MU; Rennert G; Rhenius V; Rhiem K; Risch HA; Rodriguez G; Rossing MA; Rudolph A; Salvesen HB; Sangrajrang S; Sawyer EJ; Schildkraut JM; Schmidt MK; Schmutzler RK; Sellers TA; Seynaeve C; Shah M; Shen CY; Shu XO; Sieh W; Singer CF; Sinilnikova OM; Slager S; Song H; Soucy P; Southey MC; Stenmark-Askmalm M; Stoppa-Lyonnet D; Sutter C; Swerdlow A; Tchatchou S; Teixeira MR; Teo SH; Terry KL; Terry MB; Thomassen M; Tibiletti MG; Tihomirova L; Tognazzo S; Toland AE; Tomlinson I; Torres D; Truong T; Tseng CC; Tung N; Tworoger SS; Vachon C; van den Ouweland AM; van Doorn HC; van Rensburg EJ; Van't Veer LJ; Vanderstichele A; Vergote I; Vijai J; Wang Q; Wang-Gohrke S; Weitzel JN; Wentzensen N; Whittemore AS; Wildiers H; Winqvist R; Wu AH; Yannoukakos D; Yoon SY; Yu JC; Zheng W; Zheng Y; Khanna KK; Simard J; Monteiro AN; French JD; Couch FJ; Freedman ML; Easton DF; Dunning AM; Pharoah PD; Edwards SL; Chenevix-Trench G; Antoniou AC; Gayther SA
    Nat Commun; 2016 Sep; 7():12675. PubMed ID: 27601076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.